Location History:
- Kanazawa, JP (2003)
- Osaka-fu, JP (2002 - 2005)
- Osaka, JP (2006)
- Ishikawa, JP (2009)
Company Filing History:
3 out of 229 
3 out of 19 
2 out of 832,880 Years Active: 2002-2009
Title: Takashi Suda: Innovator in Apoptosis Regulation
Introduction
Takashi Suda is a prominent inventor based in Ishikawa, Japan. He has made significant contributions to the field of medicine, particularly in the regulation of apoptosis. With a total of 5 patents, his work has paved the way for advancements in therapeutic methods.
Latest Patents
One of Takashi Suda's latest patents involves FAS ligand derived polypeptides. This invention provides a polypeptide that is useful in the field of medicines, along with a DNA that encodes the novel polypeptide. It also includes a recombinant DNA molecule containing the DNA, a transformant transformed with the DNA or the recombinant DNA molecule, and processes for the purification and production of the polypeptide. Additionally, it features an antibody that recognizes the polypeptide, an oligonucleotide complementary to the DNA, and a screening method. The polypeptide, which is Fas ligand or a fragment thereof, can be used as an effective ingredient in a medicament for regulating apoptosis in a living body. The polypeptide is obtained by identifying a DNA fragment that encodes it, transforming a desired host with a recombinant DNA molecule containing the DNA fragment, and purifying the resulting polypeptide. This polypeptide has a cytoplasmic domain, a transmembrane domain, and an extracellular domain, playing a crucial role in apoptosis. Another significant patent is a method of treating graft versus host disease by administering a Fas antagonist. This invention focuses on methods of preventing and treating diseases where apoptosis is involved.
Career Highlights
Throughout his career, Takashi Suda has worked with notable companies such as Mochida Pharmaceutical Co., Ltd. and Osaka Bioscience Institute. His innovative work has contributed to the development of new therapeutic approaches in medicine.
Collaborations
Takashi Suda has collaborated with esteemed colleagues, including Shigekazu Nagata and Tomohiro Takahashi. Their joint efforts have further advanced the research in apoptosis and its implications in medical treatments.
Conclusion
Takashi Suda's contributions to the field of medicine through his innovative patents highlight his role as a key inventor in apoptosis regulation. His work continues to influence therapeutic strategies and improve patient outcomes.